Real-life effectiveness of fluticasone furoate/vilanterol after switching from fluticasone/salmeterol or budesonide/formoterol therapy in patients with symptomatic asthma: Relvar Ellipta for Real Asthma Control Study (RERACS study)

BACKGROUND: This study evaluated the efficacy of switching therapy from fluticasone propionate/salmeterol (FP/SM) or budesonide/formoterol (BD/FM) to fluticasone furoate and vilanterol (FF/VI) at the equivalent corticosteroid dose in a real-world setting. METHODS: A prospective, 3-month, open-label,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Yasuo, Shiobara, Taichi, Arai, Ryo, Chibana, Kazuyuki, Takemasa, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330400/
https://www.ncbi.nlm.nih.gov/pubmed/32642091
http://dx.doi.org/10.21037/jtd-19-3913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330400/
https://www.ncbi.nlm.nih.gov/pubmed/32642091
http://dx.doi.org/10.21037/jtd-19-3913

Ejemplares similares